search
Back to results

Radiofrequency For Chronic Knee Pain Post-Arthroplasty (DEFIANT)

Primary Purpose

Chronic Knee Pain, Osteoarthritis, Knee

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Nerve Block with Radiofrequency Ablation
Nerve Block with Sham Radiofrequency Ablation
Sponsored by
Randall Brewer, MD, CPI
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Knee Pain focused on measuring Genicular Radiofrequency Ablation, Knee Arthroplasty, Total

Eligibility Criteria

50 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Study candidate must provide written informed consent.
  • Must be ≥ 50 years of age at the time of consent
  • Chronic knee pain despite total knee arthroplasty at least 6 months prior to consent
  • Orthopedic evaluation indicating no further surgery is warranted
  • Stable pain medication regimen for 30 days prior to baseline visit
  • Knee pain is primary pain complaint

Exclusion Criteria:

  • Acute knee pain
  • Connective tissue disorders affecting the knee
  • Serious neurologic or psychiatric disorders that would affect the outcome of the study as determined by the Principal Investigator
  • Steroid or hyaluronic acid injections into the affected knee in the past 3 months
  • Confounding pain conditions of the index leg that may affect medication requirements or study outcomes

Sites / Locations

  • WK River Cities Clinical Research Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

Nerve Block with Radiofrequency Ablation

Nerve Block with Sham Radiofrequency Ablation

Arm Description

A 10 cm 18-gauge RF cannula with a 10 mm active tip will be placed at the superior lateral, superior medial, and inferior medial nerve positions under fluoroscopic guidance. Sensory stimulation at 50 Hz will be performed to identify nerve position and to assure no motor nerves will be ablated. Lidocaine (2 ml of 2%) will be administered in each location prior to RF generator activation.

A 10 cm 18-gauge RF cannula with a 10 mm active tip will be placed at the superior lateral, superior medial, and inferior medial nerve positions under fluoroscopic guidance.Control patients will undergo the same procedure without RF generator activation. Sensory stimulation at 50 Hz will be performed to identify nerve position and to assure no motor nerves will be ablated. Lidocaine (2 ml of 2%) will be administered in each location prior to RF generator sham activation.

Outcomes

Primary Outcome Measures

Mean difference in knee pain intensities as indicated on the Visual Analog Scale

Secondary Outcome Measures

Change in Visual Analog Score of average knee pain
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS)
Change of Patient Global Assessment
Satisfaction with Radiofrequency Procedure
Rate of procedure-related Adverse Events
Rate of Serious Adverse Events

Full Information

First Posted
October 5, 2016
Last Updated
December 11, 2018
Sponsor
Randall Brewer, MD, CPI
Collaborators
Abbott Medical Devices, Abbott
search

1. Study Identification

Unique Protocol Identification Number
NCT02931435
Brief Title
Radiofrequency For Chronic Knee Pain Post-Arthroplasty
Acronym
DEFIANT
Official Title
Radiofrequency For The Treatment Of Chronic Knee Pain Following Total Knee Arthroplasty: A Double-Blind Randomized Controlled Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
December 2018
Overall Recruitment Status
Completed
Study Start Date
December 2016 (undefined)
Primary Completion Date
November 20, 2018 (Actual)
Study Completion Date
November 30, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Randall Brewer, MD, CPI
Collaborators
Abbott Medical Devices, Abbott

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Chronic knee osteoarthritis (OA) is one of the most common diseases with increasing prevalence in advanced age. Knee OA results in movement restriction, sleep disturbance, and disability. Total knee arthroplasty (TKA) is employed often in the symptomatic treatment of knee OA. It has been estimated that 3.4 million TKAs will be performed in the year 2030 in the United States alone. Many studies report rewarding outcomes for patients, but other research shows there are many patients that remain dissatisfied post-arthroplasty. The purpose of this study is to evaluate whether genicular radiofrequency ablation can relieve chronic post-arthroplasty knee pain.
Detailed Description
Chronic knee osteoarthritis (OA) is one of the most common diseases with increasing prevalence in advanced age. Knee OA results in movement restriction, sleep disturbance, and disability. Total knee arthroplasty (TKA) is employed often in the symptomatic treatment of knee OA. It has been estimated that 3.4 million TKAs will be performed in the year 2030 in the United States alone. Many studies report rewarding outcomes for patients, but other research shows there are many patients that remain dissatisfied post-arthroplasty. As the prevalence of knee arthroplasty increases, so does the frequency of revisions. It has been found that 20% of patients reporting painful knee arthroplasties were not able to be diagnosed with a specific cause and were therefore referred to a pain specialist. Pharmacologic therapy and non-surgical interventions are often employed with minimal benefit to the patient's level of disability as indicated by clinical evidence. Genicular radiofrequency ablation seems to be a safe, effective and minimally invasive therapy for chronic knee OA patients who have had a positive diagnostic block. No study has determined whether genicular radiofrequency ablation can relieve chronic post-arthroplasty knee pain. The investigators propose to examine the effect of genicular radiofrequency ablation in chronic post-arthroplasty knee pain in patients who respond positively to diagnostic nerve blocks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Knee Pain, Osteoarthritis, Knee
Keywords
Genicular Radiofrequency Ablation, Knee Arthroplasty, Total

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
9 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Nerve Block with Radiofrequency Ablation
Arm Type
Active Comparator
Arm Description
A 10 cm 18-gauge RF cannula with a 10 mm active tip will be placed at the superior lateral, superior medial, and inferior medial nerve positions under fluoroscopic guidance. Sensory stimulation at 50 Hz will be performed to identify nerve position and to assure no motor nerves will be ablated. Lidocaine (2 ml of 2%) will be administered in each location prior to RF generator activation.
Arm Title
Nerve Block with Sham Radiofrequency Ablation
Arm Type
Sham Comparator
Arm Description
A 10 cm 18-gauge RF cannula with a 10 mm active tip will be placed at the superior lateral, superior medial, and inferior medial nerve positions under fluoroscopic guidance.Control patients will undergo the same procedure without RF generator activation. Sensory stimulation at 50 Hz will be performed to identify nerve position and to assure no motor nerves will be ablated. Lidocaine (2 ml of 2%) will be administered in each location prior to RF generator sham activation.
Intervention Type
Procedure
Intervention Name(s)
Nerve Block with Radiofrequency Ablation
Intervention Description
Ablation of the genicular nerves of the knee by radiofrequency
Intervention Type
Procedure
Intervention Name(s)
Nerve Block with Sham Radiofrequency Ablation
Intervention Description
Genicular radiofrequency of the knee without neurotomy
Primary Outcome Measure Information:
Title
Mean difference in knee pain intensities as indicated on the Visual Analog Scale
Time Frame
Baseline and 6 weeks post-radiofrequency ablation
Secondary Outcome Measure Information:
Title
Change in Visual Analog Score of average knee pain
Time Frame
Baseline to 1 week, 6 weeks, and 12 weeks
Title
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame
Baseline to 1 week, 6 weeks, and 12 weeks
Title
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time Frame
Baseline to 1 week, 6 weeks, and 12 weeks
Title
Change of Patient Global Assessment
Time Frame
Baseline to 1 week, 6 weeks, and 12 weeks
Title
Satisfaction with Radiofrequency Procedure
Time Frame
Baseline to 1 week, 6 weeks, and 12 weeks
Title
Rate of procedure-related Adverse Events
Time Frame
From informed consent through study completion, up to 20 weeks
Title
Rate of Serious Adverse Events
Time Frame
From informed consent through study completion, up to 20 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Study candidate must provide written informed consent. Must be ≥ 50 years of age at the time of consent Chronic knee pain despite total knee arthroplasty at least 6 months prior to consent Orthopedic evaluation indicating no further surgery is warranted Stable pain medication regimen for 30 days prior to baseline visit Knee pain is primary pain complaint Exclusion Criteria: Acute knee pain Connective tissue disorders affecting the knee Serious neurologic or psychiatric disorders that would affect the outcome of the study as determined by the Principal Investigator Steroid or hyaluronic acid injections into the affected knee in the past 3 months Confounding pain conditions of the index leg that may affect medication requirements or study outcomes
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Randall Brewer, MD
Organizational Affiliation
WK River Cities Clinical Research Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
WK River Cities Clinical Research Center
City
Shreveport
State/Province
Louisiana
ZIP/Postal Code
71105
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
17403800
Citation
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5. doi: 10.2106/JBJS.F.00222.
Results Reference
background
PubMed Identifier
25232522
Citation
Nikolaou VS, Chytas D, Babis GC. Common controversies in total knee replacement surgery: Current evidence. World J Orthop. 2014 Sep 18;5(4):460-8. doi: 10.5312/wjo.v5.i4.460. eCollection 2014 Sep 18.
Results Reference
background
PubMed Identifier
21055873
Citation
Choi WJ, Hwang SJ, Song JG, Leem JG, Kang YU, Park PH, Shin JW. Radiofrequency treatment relieves chronic knee osteoarthritis pain: a double-blind randomized controlled trial. Pain. 2011 Mar;152(3):481-487. doi: 10.1016/j.pain.2010.09.029. Epub 2010 Nov 4.
Results Reference
background
PubMed Identifier
22234706
Citation
Al-Hadithy N, Rozati H, Sewell MD, Dodds AL, Brooks P, Chatoo M. Causes of a painful total knee arthroplasty. Are patients still receiving total knee arthroplasty for extrinsic pathologies? Int Orthop. 2012 Jun;36(6):1185-9. doi: 10.1007/s00264-011-1473-6. Epub 2012 Jan 11.
Results Reference
background

Learn more about this trial

Radiofrequency For Chronic Knee Pain Post-Arthroplasty

We'll reach out to this number within 24 hrs